期刊
JOURNAL OF NEURAL TRANSMISSION
卷 127, 期 4, 页码 661-672出版社
SPRINGER WIEN
DOI: 10.1007/s00702-020-02172-4
关键词
Delta opioid receptor; Pain; Primary afferents; G protein-coupled receptors; Trafficking
资金
- Canadian Institutes of Health Research (CIHR) [MOP-136871, PJT-162103]
- Fonds de la Recherche du Quebec-Sante (FRQ-S) [30851]
The use of opioids for the relief of pain and headache disorders has been studied for years. Nowadays, particularly because of its ability to produce analgesia in various pain models, delta opioid receptor (DOPr) emerges as a promising target for the development of new pain therapies. Indeed, their potential to avoid the unwanted effects commonly observed with clinically used opioids acting at the mu opioid receptor (MOPr) suggests that DOPr agonists could be a therapeutic option. In this review, we discuss the use of opioids in the management of pain in addition to describing the evidence of the analgesic potency of DOPr agonists in animal models.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据